- Home
- ALT vs VBNK Comparison
ALT vs VBNK Comparison
Compare ALT & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- VBNK
- Stock Information
- Founded
- ALT 1997
- VBNK 1980
- Country
- ALT United States
- VBNK Canada
- Employees
- ALT N/A
- VBNK N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- VBNK Commercial Banks
- Sector
- ALT Health Care
- VBNK Finance
- Exchange
- ALT Nasdaq
- VBNK Nasdaq
- Market Cap
- ALT 348.6M
- VBNK 398.2M
- IPO Year
- ALT N/A
- VBNK 2021
- Fundamental
- Price
- ALT $4.00
- VBNK $11.86
- Analyst Decision
- ALT Strong Buy
- VBNK Buy
- Analyst Count
- ALT 7
- VBNK 2
- Target Price
- ALT $16.50
- VBNK $15.00
- AVG Volume (30 Days)
- ALT 2.7M
- VBNK 64.2K
- Earning Date
- ALT 11-07-2025
- VBNK 12-08-2025
- Dividend Yield
- ALT N/A
- VBNK 0.60%
- EPS Growth
- ALT N/A
- VBNK N/A
- EPS
- ALT N/A
- VBNK 0.69
- Revenue
- ALT $20,000.00
- VBNK $82,297,771.00
- Revenue This Year
- ALT N/A
- VBNK $8.39
- Revenue Next Year
- ALT N/A
- VBNK $31.45
- P/E Ratio
- ALT N/A
- VBNK $17.29
- Revenue Growth
- ALT N/A
- VBNK 0.07
- 52 Week Low
- ALT $2.90
- VBNK $8.51
- 52 Week High
- ALT $11.16
- VBNK $18.38
- Technical
- Relative Strength Index (RSI)
- ALT 52.72
- VBNK 45.20
- Support Level
- ALT $3.83
- VBNK $11.81
- Resistance Level
- ALT $4.15
- VBNK $12.17
- Average True Range (ATR)
- ALT 0.17
- VBNK 0.29
- MACD
- ALT 0.00
- VBNK -0.05
- Stochastic Oscillator
- ALT 58.90
- VBNK 18.72
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About VBNK VersaBank
VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.